NASH Clinical comprises a global network of clinicians, investigators, and experts in the NASH field. NASH Clinical’s mission is to help decrease the problems that arise from nonalcoholic steatohepatitis (NASH) worldwide.
The participating clinicians in NASH Clinical are endocrinologists, gastroenterologists, diabetologists, and general internists. They have connections with numerous hospitals worldwide. NASH Clinical’s goals are to raise awareness and share insights about this endemic disease, collaboratively create easy and accurate diagnostic tools that can be used to identify patients, and to conduct fatty liver clinical trials that could help mitigate the risks associated with this disease.
NASH Clinical was created by Julius Clinical in 2018. The founding members are academic researchers who were — and continue to be — connected through research, education, or other activities in this area.
With the deep experience of NASH Clinical’s sites and investigators, and the cohesion derived from lengthy relationships and fast, transparent communication, we have the tools in place to precisely determine the potential of your novel NASH treatment.
Interdisciplinary collaboration is essential to combat NASH. The aim of this network is to work collaboratively, discover and disseminate insights, create advanced diagnostic tools, and conduct groundbreaking NASH clinical trials.
Recruitment in NASH is an especially difficult hurdle, with screening failure rates that often exceed 95%. NASH Clinical’s scientific approach and wealth of experience have helped refine our recruitment procedures to speed study startup and project timelines.
The upcoming NASH clinical webinar promises to be an insightful and informative session, with our scientific officer Manuel Castro Cabezas as the guest speaker. Manuel will be sharing his expertise on the topic of "Why NASH trials frequently fa...
During the 5th Global NASH Congress in London, Our Chief Scientific Officer Prof. Dr. D.E. Grobbee was one of the speakers and presented: Getting GRIP on NASH; Implementation of an International Clinical Screening Program. During this presentat...
In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...
Explore our NASH capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields
